COPD and stroke: Are systemic inflammation and oxidative stress the missing links?

Clinical Science

Volumn 130, Issue 13, 2016, Pages 1039-1050

  Austin, Victoria ^a   Crack, Peter J ^b   Bozinovski, Steven ^a,b   Miller, Alyson A ^a   Vlahos, Ross ^a,b  

^a RMIT UNIVERSITY   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Cardiovascular disease; Chronic obstructive pulmonary disease (COPD); Comorbidities; Oxidative stress; Stroke; Systemic inflammation

Indexed keywords

ACUTE DISEASE; AGING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHRONIC OBSTRUCTIVE LUNG DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE EXACERBATION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INFLAMMATION; LUNG FUNCTION; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SMOKING; SYSTEMIC INFLAMMATION; ANIMAL; COMPLICATION; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK FACTOR;

ANIMALS; HUMANS; INFLAMMATION; OXIDATIVE STRESS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; SMOKING; STROKE;

EID: 85014124889     PISSN: 01435221     EISSN: 14708736     Source Type: Journal    
DOI: 10.1042/CS20160043     Document Type: Review

References (177)

1. Vestbo, J., Hurd, S.S., Agustí, A.G., Jones, P.W., Vogelmeier, C., Anzueto, A., Barnes, P.J., Fabbri, L.M., Martinez, F.J., Nishimura, M. et al. (2013) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 187, 347-365
2. Srivastava, K., Thakur, D., Sharma, S. and Punekar, Y.S. (2015) Systematic review of humanistic and economic burden of symptomatic chronic obstructive pulmonary disease. Pharmacoeconomics 33, 467-488
3. Sullivan, S.D., Ramsey, S.D. and Lee, T.A. (2000) The economic burden of COPD. Chest 117, 5S-9S
4. Ford, E.S., Murphy, L.B., Khavjou, O., Giles, W.H., Holt, J.B. and Croft, J.B. (2015) Total and state-specific medical and absenteeism costs of copd among adults aged ≥ 18 years in the United States for 2010 and projections through 2020. Chest 147, 31-45
5. Sin, D.D., Anthonisen, N.R., Soriano, J.B. and Agusti, A.G. (2006) Mortality in COPD: role of comorbidities. Eur. Respir. J. 28, 1245-1257
6. Sin, D.D. and Man, S.F. (2005) Chronic obstructive pulmonary disease: a novel risk factor for cardiovascular disease. Can. J. Physiol. Pharmacol. 83, 8-13
7. Maclay, J.D. and MacNee, W. (2013) Cardiovascular disease in COPD: mechanisms. Chest 143, 798-807
8. Donaldson, G.C., Hurst, J.R., Smith, C.J., Hubbard, R.B. and Wedzicha, J.A. (2010) Increased risk of myocardial infarction and stroke following exacerbation of COPD. Chest 137, 1091-1097
9. Portegies, M.L., Lahousse, L., Joos, G.F., Hofman, A., Koudstaal, P.J., Stricker, B.H., Brusselle, G.G. and Ikram, M.A. (2016) Chronic obstructive pulmonary disease and the risk of stroke: The Rotterdam Study. Am. J. Respir. Crit. Care Med. 193, 251-258
10. Pauwels, R.A. and Rabe, K.F. (2004) Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet 364, 613-620
11. Pauwels, R.A., Buist, A.S., Calverley, P.M., Jenkins, C.R. and Hurd, S.S. (2001) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am. J. Respir. Crit. Care Med. 163, 1256-1276
12. Barnes, P.J., Shapiro, S.D. and Pauwels, R.A. (2003) Chronic obstructive pulmonary disease: molecular and cellular mechanisms. Eur. Respir. J. 22, 672-688
13. Dennis, R.J., Maldonado, D., Norman, S., Baena, E. and Martinez, G. (1996) Woodsmoke exposure and risk for obstructive airways disease among women. Chest 109, 115-119
14. Barnes, P.J. (2014) Cellular and molecular mechanisms of chronic obstructive pulmonary disease. Clin. Chest Med. 35, 71-86
15. Vlahos, R. and Bozinovski, S. (2014) Recent advances in pre-clinical mouse models of COPD. Clin. Sci. (Lond.) 126, 253-265
16. Vlahos, R., Bozinovski, S., Hamilton, J.A. and Anderson, G.P. (2006) Therapeutic potential of treating chronic obstructive pulmonary disease (COPD) by neutralising granulocyte macrophage-colony stimulating factor (GM-CSF). Pharmacol. Ther. 112, 106-115
17. Barnes, P.J. (2013) New anti-inflammatory targets for chronic obstructive pulmonary disease. Nat. Rev. Drug Discov. 12, 543-559
18. Mackay, A.J. and Hurst, J.R. (2013) COPD exacerbations: causes, prevention, and treatment. Immunol Allergy Clin. North Am. 33, 95-115
19. Rohde, G., Wiethege, A., Borg, I., Kauth, M., Bauer, T.T., Gillissen, A., Bufe, A. and Schultze-Werninghaus, G. (2003) Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalisation: a case-control study. Thorax 58, 37-42
20. Seemungal, T., Harper-Owen, R., Bhowmik, A., Moric, I., Sanderson, G., Message, S., Maccallum, P., Meade, T.W., Jeffries, D.J., Johnston, S.L. and Wedzicha, J.A. (2001) Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 164, 1618-1623
21. Seemungal, T.A., Donaldson, G.C., Bhowmik, A., Jeffries, D.J. and Wedzicha, J.A. (2000) Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 161, 1608-1613
22. Crooks, S.W., Bayley, D.L., Hill, S.L. and Stockley, R.A. (2000) Bronchial inflammation in acute bacterial exacerbations of chronic bronchitis: the role of leukotriene B4. Eur. Respir. J. 15, 274-280
23. Aaron, S.D., Angel, J.B., Lunau, M., Wright, K., Fex, C., Le Saux, N. and Dales, R.E. (2001) Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 163, 349-355
24. Bhowmik, A., Seemungal, T.A., Sapsford, R.J. and Wedzicha, J.A. (2000) Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations. Thorax 55, 114-120
25. Gompertz, S., Bayley, D.L., Hill, S.L. and Stockley, R.A. (2001) Relationship between airway inflammation and the frequency of exacerbations in patients with smoking related COPD. Thorax 56, 36-41
26. Caramori, G., Romagnoli, M., Casolari, P., Bellettato, C., Casoni, G., Boschetto, P., Fan Chung, K., Barnes, P.J., Adcock, I.M., Ciaccia, A. et al. (2003) Nuclear localisation of p65 in sputum macrophages but not in sputum neutrophils during COPD exacerbations. Thorax 58, 348-351
27. Kirkham, P.A. and Barnes, P.J. (2013) Oxidative stress in copd. Chest 144, 266-273
28. Bernardo, I., Bozinovski, S. and Vlahos, R. (2015) Targeting oxidant-dependent mechanisms for the treatment of COPD and its comorbidities. Pharmacol. Ther. 155, 60-79
29. Rahman, I. (2012) Pharmacological antioxidant strategies as therapeutic interventions for COPD. Biochim. Biophys. Acta 1822, 714-728
30. Vlahos, R., Stambas, J., Bozinovski, S., Broughton, B.R., Drummond, G.R. and Selemidis, S. (2011) Inhibition of nox2 oxidase activity ameliorates influenza a virus-induced lung inflammation. PLoS Pathog 7, e1001271
31. Vlahos, R., Stambas, J. and Selemidis, S. (2012) Suppressing production of reactive oxygen species (ROS) for influenza A virus therapy. Trends Pharmacol. Sci. 33, 3-8
32. Vlahos, R. and Selemidis, S. (2014) NADPH oxidases as novel pharmacologic targets against influenza A virus infection. Mol. Pharmacol. 86, 747-759
33. Drummond, G.R., Selemidis, S., Griendling, K.K. and Sobey, C.G. (2011) Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets. Nat. Rev. Drug Dis. 10, 453-471
34. Dahl, M., Bowler, R.P., Juul, K., Crapo, J.D., Levy, S. and Nordestgaard, B.G. (2008) Superoxide dismutase 3 polymorphism associated with reduced lung function in two large populations. Am. J. Respir. Crit. Care Med. 178, 906-912
35. Nowak, D., Antczak, A., Krol, M., Pietras, T., Shariati, B., Bialasiewicz, P., Jeczkowski, K. and Kula, P. (1996) Increased content of hydrogen peroxide in the expired breath of cigarette smokers. Eur. Respir. J. 9, 652-657
36. Dekhuijzen, P.N., Aben, K.K., Dekker, I., Aarts, L.P., Wielders, P.L., van Herwaarden, C.L. and Bast, A. (1996) Increased exhalation of hydrogen peroxide in patients with stable and unstable chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 154, 813-816
37. Duong, C., Seow, H.J., Bozinovski, S., Crack, P.J., Anderson, G.P. and Vlahos, R. (2010) Glutathione peroxidase-1 protects against cigarette smoke-induced lung inflammation in mice. Am. J. Physiol. Lung Cell Mol. Physiol. 299, L425-L433
38. Rahman, I. (2005) Oxidative stress in pathogenesis of chronic obstructive pulmonary disease: cellular and molecular mechanisms. Cell Biochem. Biophys. 43, 167-188
39. Drath, D.B., Karnovsky, M.L. and Huber, G.L. (1979) The effects of experimental exposure to tobacco smoke on the oxidative metabolism of alveolar macrophages. J. Reticuloendothel. Soc. 25, 597-604
40. Schaberg, T., Klein, U., Rau, M., Eller, J. and Lode, H. (1995) Subpopulations of alveolar macrophages in smokers and nonsmokers: relation to the expression of CD11/CD18 molecules and superoxide anion production. Am. J. Respir. Crit. Care Med. 151, 1551-1558
41. Mateos, F., Brock, J.H. and Perez-Arellano, J.L. (1998) Iron metabolism in the lower respiratory tract. Thorax 53, 594-600
42. Thompson, A.B., Bohling, T., Heires, A., Linder, J. and Rennard, S.I. (1991) Lower respiratory tract iron burden is increased in association with cigarette smoking. J. Lab. Clin. Med. 117, 493-499
43. Wesselius, L.J., Nelson, M.E. and Skikne, B.S. (1994) Increased release of ferritin and iron by iron-loaded alveolar macrophages in cigarette smokers. Am. J. Respir. Crit. Care Med. 150, 690-695
44. Gan, W.Q., Man, S.F., Senthilselvan, A. and Sin, D.D. (2004) Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 59, 574-580
45. Barnes, P.J. and Celli, B.R. (2009) Systemic manifestations and comorbidities of COPD. Eur. Respir. J. 33, 1165-1185
46. de Torres, J.P., Pinto-Plata, V., Casanova, C., Mullerova, H., Cordoba-Lanus, E., Muros de Fuentes, M., Aguirre-Jaime, A. and Celli, B.R. (2008) C-reactive protein levels and survival in patients with moderate to very severe COPD. Chest 133, 1336-1343
47. Kazmierczak, M., Ciebiada, M., Pekala-Wojciechowska, A., Pawlowski, M., Nielepkowicz-Gozdzinska, A. and Antczak, A. (2015) Evaluation of markers of inflammation and oxidative stress in COPD patients with or without cardiovascular comorbidities. Heart Lung Circ. 24, 817-823
48. Wedzicha, J.A. and Seemungal, T.A. (2007) COPD exacerbations: defining their cause and prevention. Lancet 370, 786-796
49. Agusti, A.G. (2005) Systemic effects of chronic obstructive pulmonary disease. Proc. Am. Thorac. Soc. 2, 367-370, discussion 371-362
50. Kirkham, P.A. and Barnes, P.J. (2013) Oxidative stress in COPD. Chest 144, 266-273
51. Gea, J., Pascual, S., Casadevall, C., Orozco-Levi, M. and Barreiro, E. (2015) Muscle dysfunction in chronic obstructive pulmonary disease: update on causes and biological findings. J. Thorac. Dis. 7, E418-E438
52. Rahman, I., van Schadewijk, A.A., Crowther, A.J., Hiemstra, P.S., Stolk, J., MacNee, W. and De Boer, W.I. (2002) 4-Hydroxy-2-nonenal, a specific lipid peroxidation product, is elevated in lungs of patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 166, 490-495
53. Barreiro, E., Peinado, V.I., Galdiz, J.B., Ferrer, E., Marin-Corral, J., Sanchez, F., Gea, J. and Barbera, J.A. (2010) Cigarette smoke-induced oxidative stress: A role in chronic obstructive pulmonary disease skeletal muscle dysfunction. Am. J. Respir. Crit. Care Med. 182, 477-488
54. Hartmann, S.E., Pialoux, V., Leigh, R. and Poulin, M.J. (2012) Decreased cerebrovascular response to CO2 in post-menopausal females with COPD: role of oxidative stress. Eur. Respir. J. 40, 1354-1361
55. Can, U., Yerlikaya, F.H. and Yosunkaya, S. (2015) Role of oxidative stress and serum lipid levels in stable chronic obstructive pulmonary disease. J. Chin. Med. Assoc. 78, 702-708
56. Vlahos, R. and Bozinovski, S. (2013) Glutathione peroxidase-1 as a novel therapeutic target for COPD. Redox. Report. 18, 142-149
57. Maury, J., Gouzi, F., De Rigal, P., Heraud, N., Pincemail, J., Molinari, N., Pomies, P., Laoudj-Chenivesse, D., Mercier, J., Prefaut, C. and Hayot, M. (2015) Heterogeneity of systemic oxidative stress profiles in COPD: A Potential Role of Gender. Oxid. Med. Cell Longev. 2015, ID 201843, 11
58. Bhatt, S.P., Wells, J.M. and Dransfield, M.T. (2014) Cardiovascular disease in COPD: a call for action. Lancet Respir. Med. 2, 783-785
59. Bhatt, S.P. and Dransfield, M.T. (2013) Chronic obstructive pulmonary disease and cardiovascular disease. Transl. Res. 162, 237-251
60. Dalal, A.A., Shah, M., Lunacsek, O. and Hanania, N.A. (2011) Clinical and economic burden of patients diagnosed with COPD with comorbid cardiovascular disease. Respir. Med. 105, 1516-1522
61. Sin, D.D. and Paul Man, S.F. (2005) Chronic obstructive pulmonary disease as a risk factor for cardiovascular morbidity and mortality. Proc. Am. Thorac. Soc. 2, 8-11
62. Chatila, W., Thomashow, B.M., Minai, O.A., Criner, G.J. and Make, B. (2008) Comorbidities in chronic obstructive pulmonary disease. Proc. Am. Thorac. Soc. 5, 549-555
63. Berger, J.S., Sanborn, T.A., Sherman, W. and Brown, D.L. (2004) Effect of chronic obstructive pulmonary disease on survival of patients with coronary heart disease having percutaneous coronary intervention. Am. J. Cardiol. 94, 649-651
64. Sin, D.D., Wu, L. and Man, S.F. (2005) The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature. Chest 127, 1952-1959
65. Curkendall, S.M., DeLuise, C., Jones, J.K., Lanes, S., Stang, M.R., Goehring, Jr, E. and She, D. (2006) Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients. Ann. Epidemiol. 16, 63-70
66. de Barrose Silva, P.G.M., Califf, R.M., Sun, J.L., McMurray, J.J., Holman, R., Haffner, S., Thomas, L. and Lopes, R.D. (2014) Chronic obstructive pulmonary disease and cardiovascular risk: Insights from the NAVIGATOR trial. Int. J. Cardiol. 176, 1126-1128
67. Stefanelli, F., Meoli, I., Cobuccio, R., Curcio, C., Amore, D., Casazza, D., Tracey, M. and Rocco, G. (2013) High-intensity training and cardiopulmonary exercise testing in patients with chronic obstructive pulmonary disease and non-small-cell lung cancer undergoing lobectomy. Eur. J. Cardiothorac. Surg. 44, e260-e265
68. Patel, A.R., Kowlessar, B.S., Donaldson, G.C., Mackay, A.J., Singh, R., George, S.N., Garcha, D.S., Wedzicha, J.A. and Hurst, J.R. (2013) Cardiovascular risk, myocardial injury, and exacerbations of chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 188, 1091-1099
69. Pastor, M.D., Nogal, A., Molina-Pinelo, S., Melendez, R., Romero-Romero, B., Mediano, M.D., Lopez-Campos, J.L., Garcia-Carbonero, R., Sanchez-Gastaldo, A., Carnero, A. and Paz-Ares, L. (2013) Identification of oxidative stress related proteins as biomarkers for lung cancer and chronic obstructive pulmonary disease in bronchoalveolar lavage. Int. J. Mol. Sci. 14, 3440-3455
70. Mozaffarian, D., Benjamin, E.J., Go, A.S., Arnett, D.K., Blaha, M.J., Cushman, M., de Ferranti, S., Despres, J.P., Fullerton, H.J., Howard, V.J. et al. (2015) Heart disease and stroke statistics-2015 update: a report from the American Heart Association. Circulation 131, e29-e322
71. Allen, C.L. and Bayraktutan, U. (2008) Risk factors for ischaemic stroke. Int. J. Stroke 3, 105-116
72. Dirnagl, U., Iadecola, C. and Moskowitz, M.A. (1999) Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 22, 391-397
73. Moskowitz, M.A., Lo, E.H. and Iadecola, C. (2010) The science of stroke: mechanisms in search of treatments. Neuron 67, 181-198
74. Allen, C.L. and Bayraktutan, U. (2009) Oxidative stress and its role in the pathogenesis of ischaemic stroke. Int. J. Stroke 4, 461-470
75. Kahles, T. and Brandes, R.P. (2013) Which NADPH oxidase isoform is relevant for ischemic stroke? The case for nox 2. Antioxid. Redox Signal. 18, 1400-1417
76. De Silva, T.M., Brait, V.H., Drummond, G.R., Sobey, C.G. and Miller, A.A. (2011) Nox2 oxidase activity accounts for the oxidative stress and vasomotor dysfunction in mouse cerebral arteries following ischemic stroke. PLoS One 6, e28393
77. Kahles, T., Luedike, P., Endres, M., Galla, H.J., Steinmetz, H., Busse, R., Neumann-Haefelin, T. and Brandes, R.P. (2007) NADPH oxidase plays a central role in blood-brain barrier damage in experimental stroke. Stroke 38, 3000-3006
78. Kleinschnitz, C., Grund, H., Wingler, K., Armitage, M.E., Jones, E., Mittal, M., Barit, D., Schwarz, T., Geis, C., Kraft, P. et al. (2010) Post-stroke inhibition of induced NADPH oxidase type 4 prevents oxidative stress and neurodegeneration. PLoS Biol. 8, pii: e1000479
79. Jackman, K.A., Miller, A.A., De Silva, T.M., Crack, P.J., Drummond, G.R. and Sobey, C.G. (2009) Reduction of cerebral infarct volume by apocynin requires pretreatment and is absent in Nox2-deficient mice. Br. J. Pharmacol. 156, 680-688
80. Kamel, H. and Iadecola, C. (2012) Brain-immune interactions and ischemic stroke: clinical implications. Arch. Neurol. 69, 576-581
81. Iadecola, C. and Anrather, J. (2011) The immunology of stroke: from mechanisms to translation. Nat. Med. 17, 796-808
82. Jackman, K. and Iadecola, C. (2015) Neurovascular regulation in the ischemic brain. Antioxid. Redox Signal. 22, 149-160
83. Stanimirovic, D.B. and Friedman, A. (2012) Pathophysiology of the neurovascular unit: disease cause or consequence? J. Cereb. Blood Flow Metab. 32, 1207-1221
84. Qureshi, A.I., Mendelow, A.D. and Hanley, D.F. (2009) Intracerebral haemorrhage. Lancet 373, 1632-1644
85. Aronowski, J. and Zhao, X. (2011) Molecular pathophysiology of cerebral hemorrhage: secondary brain injury. Stroke 42, 1781-1786
86. Gulsvik, A.K., Gulsvik, A., Skovlund, E., Thelle, D.S., Mowé, M., Humerfelt, S. and Wyller, T.B. (2012) The association between lung function and fatal stroke in a community followed for 4 decades. J. Epidemiol. Community Health. 66, 1030-1036
87. Truelsen, T., Prescott, E., Lange, P., Schnohr, P. and Boysen, G. (2001) Lung function and risk of fatal and non-fatal stroke. The Copenhagen City Heart Study. Int. J. Epidemiol. 30, 145-151
88. Wannamethee, S.G., Shaper, A.G. and Ebrahim, S. (1995) Respiratory function and risk of stroke. Stroke 26, 2004-2010
89. Söderholm, M., Zia, E., Hedblad, B. and Engström, G. (2012) Lung Function as a risk factor for subarachnoid hemorrhage: a prospective cohort study. Stroke 43, 2598-2603
90. Hozawa, A., Billings, J.L., Shahar, E., Ohira, T., Rosamond, W.D. and Folsom, A.R. (2006) Lung function and ischemic stroke incidence: the atherosclerosis risk in communities study. Chest 130, 1642-1649
91. Liao, D., Higgins, M., Bryan, N.R., Eigenbrodt, M.L., Chambless, L.E., Lamar, V., Burke, G.L. and Heiss, G. (1999) Lower pulmonary function and cerebral subclinical abnormalities detected by MRI: the atherosclerosis risk in communities study. Chest 116, 150-156
92. Longstreth, Jr, W.T., Manolio, T.A., Arnold, A., Burke, G.L., Bryan, N., Jungreis, C.A., Enright, P.L., O'Leary, D. and Fried, L. (1996) Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people: the cardiovascular health study. Stroke 27, 1274-1282
93. Kuller, L.H., Longstreth, W.T., Arnold, A.M., Bernick, C., Bryan, R.N. and Beauchamp, N.J. (2004) White matter hyperintensity on cranial magnetic resonance imaging: a predictor of stroke. Stroke 35, 1821-1825
94. Taki, Y., Kinomura, S., Ebihara, S., Thyreau, B., Sato, K., Goto, R., Kakizaki, M., Tsuji, I., Kawashima, R. and Fukuda, H. (2013) Correlation between pulmonary function and brain volume in healthy elderly subjects. Neuroradiology 55, 689-695
95. Liao, D., Higgins, M., Bryan, N.R., Eigenbrodt, M.L., Chambless, L.E., Lamar, V., Burke, G.L. and Heiss, G. (1999) Lower pulmonary function and cerebral subclinical abnormalities detected by MRI: the atherosclerosis risk in communities study. Chest 116, 150-156
96. Schroeder, E.B., Welch, V.L., Evans, G.W. and Heiss, G. (2005) Impaired lung function and subclinical atherosclerosis: the ARIC study. Atherosclerosis 180, 367-373
97. Friedman, G.D., Klatsky, A.L. and Siegelaub, A.B. (1976) Lung function and risk of myocardial infarction and sudden cardiac death. N. Engl. J. Med. 294, 1071-1075
98. Johnston, A.K., Mannino, D.M., Hagan, G.W., Davis, K.J. and Kiri, V.A. (2008) Relationship between lung function impairment and incidence or recurrence of cardiovascular events in a middle-aged cohort. Thorax 63, 599-605
99. Finkelstein, J., Cha, E. and Scharf, S.M. (2009) Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity. Int. J. Chron. Obstruct. Pulmon. Dis. 4, 337-349
100. Feary, J.R., Rodrigues, L.C., Smith, C.J., Hubbard, R.B. and Gibson, J.E. (2010) Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care. Thorax 65, 956-962
101. Schneider, C., Bothner, U., Jick, S.S. and Meier, C.R. (2010) Chronic obstructive pulmonary disease and the risk of cardiovascular diseases. Eur. J. Epidemiol. 25, 253-260
102. Lahousse, L., Vernooij, M.W., Darweesh, S.K., Akoudad, S., Loth, D.W., Joos, G.F., Hofman, A., Stricker, B.H., Ikram, M.A. and Brusselle, G.G. (2013) Chronic obstructive pulmonary disease and cerebral microbleeds. The Rotterdam Study. Am. J. Respir. Crit. Care Med. 188, 783-788
103. Haeusler, K.G., Herm, J., Konieczny, M., Grittner, U., Lainscak, M., Endres, M. and Doehner, W. (2015) Impact of chronic inflammatory airway disease on stroke severity and long-term survival after ischemic stroke-a retrospective analysis. BMC Neurol. 15, 164
104. Ward, K., Seymour, J., Steier, J., Jolley, C.J., Polkey, M.I., Kalra, L. and Moxham, J. (2010) Acute ischaemic hemispheric stroke is associated with impairment of reflex in addition to voluntary cough. Eur. Respir. J. 36, 1383-1390
105. Pollock, R.D., Rafferty, G.F., Moxham, J. and Kalra, L. (2013) Respiratory muscle strength and training in stroke and neurology: a systematic review. Int. J. Stroke 8, 124-130
106. Kumar, S., Selim, M.H. and Caplan, L.R. (2010) Medical complications after stroke. Lancet Neurol. 9, 105-118
107. Rochester, C.L. and Mohsenin, V. (2002) Respiratory complications of stroke. Semin. Respir. Crit. Care Med. 23, 248-260
108. Allen, C.L. and Bayraktutan, U. (2008) Risk factors for ischaemic stroke. Int. J. Stroke 3, 105-116
109. O'Donnell, M.J., Xavier, D., Liu, L., Zhang, H., Chin, S.L., Rao-Melacini, P., Rangarajan, S., Islam, S., Pais, P., McQueen, M.J. et al. (2010) Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet 376, 112-123
110. Hajdu, M.A., Heistad, D.D., Siems, J.E. and Baumbach, G.L. (1990) Effects of aging on mechanics and composition of cerebral arterioles in rats. Circ. Res. 66, 1747-1754
111. Sun, Z. (2014) Atherosclerosis and atheroma plaque rupture: normal anatomy of vasa vasorum and their role associated with atherosclerosis. ScientificWorldJournal 2014, 285058
112. Scallan, C., Doonan, R.J. and Daskalopoulou, S.S. (2010) The combined effect of hypertension and smoking on arterial stiffness. Clin. Exp. Hypertens 32, 319-328
113. Wang, J.C. and Bennett, M. (2012) Aging and atherosclerosis: mechanisms, functional consequences, and potential therapeutics for cellular senescence. Circ. Res. 111, 245-259
114. Fabris, F., Zanocchi, M., Bo, M., Fonte, G., Poli, L., Bergoglio, I., Ferrario, E. and Pernigotti, L. (1994) Carotid plaque, aging, and risk factors. A study of 457 subjects. Stroke 25, 1133-1140
115. Sullivan, J.C., Loomis, E.D., Collins, M., Imig, J.D., Inscho, E.W. and Pollock, J.S. (2004) Age-related alterations in NOS and oxidative stress in mesenteric arteries from male and female rats. J. Appl. Physiol. (1985). 97, 1268-1274
116. Mayhan, W.G., Faraci, F.M., Baumbach, G.L. and Heistad, D.D. (1990) Effects of aging on responses of cerebral arterioles. Am. J. Physiol. 258, H1138-H1143
117. Mayhan, W.G. and Patel, K.P. (1997) Effect of nicotine on endothelium-dependent arteriolar dilatation in vivo. Am. J. Physiol. 272, H2337-2342
118. Mayhan, W.G. and Sharpe, G.M. (1996) Effect of cigarette smoke extract on arteriolar dilatation in vivo. J. Appl. Physiol. (1985). 81, 1996-2003
119. Mayhan, W.G., Arrick, D.M., Sharpe, G.M. and Sun, H. (2008) Age-related alterations in reactivity of cerebral arterioles: role of oxidative stress. Microcirculation 15, 225-236
120. Iida, H., Iida, M., Takenaka, M., Fukuoka, N. and Dohi, S. (2008) Rho-kinase inhibitor and nicotinamide adenine dinucleotide phosphate oxidase inhibitor prevent impairment of endothelium-dependent cerebral vasodilation by acute cigarette smoking in rats. J. Renin. Angiotensin Aldosterone Syst. 9, 89-94
121. Iida, H., Iida, M., Takenaka, M., Fujiwara, H. and Dohi, S. (2006) Angiotensin II type 1 (AT1)-receptor blocker prevents impairment of endothelium-dependent cerebral vasodilation by acute cigarette smoking in rats. Life Sci. 78, 1310-1316
122. Roquer, J., Segura, T., Serena, J. and Castillo, J. (2009) Endothelial dysfunction, vascular disease and stroke: the ARTICO study. Cerebrovasc. Dis. 27 Suppl 1, 25-37
123. Zimmermann, C., Wimmer, M. and Haberl, R.L. (2004) L-arginine-mediated vasoreactivity in patients with a risk of stroke. Cerebrovasc. Dis. 17, 128-133
124. Park, L., Anrather, J., Girouard, H., Zhou, P. and Iadecola, C. (2007) Nox2-derived reactive oxygen species mediate neurovascular dysregulation in the aging mouse brain. J. Cereb. Blood Flow Metab. 27, 1908-1918
125. Olah, L., Raiter, Y., Candale, C., Molnar, S., Rosengarten, B., Bornstein, N.M. and Csiba, L. (2008) Visually evoked cerebral vasomotor response in smoking and nonsmoking young adults, investigated by functional transcranial Doppler. Nicotine Tob. Res. 10, 353-358
126. Boms, N., Yonai, Y., Molnar, S., Rosengarten, B., Bornstein, N.M., Csiba, L. and Olah, L. (2010) Effect of smoking cessation on visually evoked cerebral blood flow response in healthy volunteers. J. Vasc. Res. 47, 214-220
127. Toth, P., Tarantini, S., Tucsek, Z., Ashpole, N.M., Sosnowska, D., Gautam, T., Ballabh, P., Koller, A., Sonntag, W.E., Csiszar, A. and Ungvari, Z. (2014) Resveratrol treatment rescues neurovascular coupling in aged mice: role of improved cerebromicrovascular endothelial function and downregulation of NADPH oxidase. Am. J. Physiol. Heart Circ. Physiol. 306, H299-308
128. Takechi, R., Pallebage-Gamarallage, M.M., Lam, V., Giles, C. and Mamo, J.C. (2013) Aging-related changes in blood-brain barrier integrity and the effect of dietary fat. Neurodegener Dis. 12, 125-135
129. Elahy, M., Jackaman, C., Mamo, J.C., Lam, V., Dhaliwal, S.S., Giles, C., Nelson, D. and Takechi, R. (2015) Blood-brain barrier dysfunction developed during normal aging is associated with inflammation and loss of tight junctions but not with leukocyte recruitment. Immun. Ageing 12, 2
130. Kaisar, M.A., Prasad, S. and Cucullo, L. (2015) Protecting the BBB endothelium against cigarette smoke-induced oxidative stress using popular antioxidants: Are they really beneficial? Brain Res. 1627, 90-100
131. Miller, A.A., Budzyn, K. and Sobey, C.G. (2010) Vascular dysfunction in cerebrovascular disease: mechanisms and therapeutic intervention. Clin. Sci. (Lond). 119, 1-17
132. Marchesi, C., Paradis, P. and Schiffrin, E.L. (2008) Role of the renin-angiotensin system in vascular inflammation. Trends Pharmacol. Sci. 29, 367-374
133. Basuroy, S., Bhattacharya, S., Leffler, C.W. and Parfenova, H. (2009) Nox4 NADPH oxidase mediates oxidative stress and apoptosis caused by TNF-alpha in cerebral vascular endothelial cells. Am. J. Physiol. Cell Physiol. 296, C422-432
134. Schrader, L.I., Kinzenbaw, D.A., Johnson, A.W., Faraci, F.M. and Didion, S.P. (2007) IL-6 deficiency protects against angiotensin II induced endothelial dysfunction and hypertrophy. Arterioscler. Thromb. Vasc. Biol. 27, 2576-2581
135. Chan, C.T., Moore, J.P., Budzyn, K., Guida, E., Diep, H., Vinh, A., Jones, E.S., Widdop, R.E., Armitage, J.A., Sakkal, S. et al. (2012) Reversal of vascular macrophage accumulation and hypertension by a CCR2 antagonist in deoxycorticosterone/salt-treated mice. Hypertension 60, 1207-1212
136. Guzik, T.J., Hoch, N.E., Brown, K.A., McCann, L.A., Rahman, A., Dikalov, S., Goronzy, J., Weyand, C. and Harrison, D.G. (2007) Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J. Exp. Med. 204, 2449-2460
137. Faraci, F.M. (2011) Protecting against vascular disease in brain. Am. J. Physiol. Heart Circ. Physiol. 300, H1566-1582
138. Husain, K., Hernandez, W., Ansari, R.A. and Ferder, L. (2015) Inflammation, oxidative stress and renin angiotensin system in atherosclerosis. World J. Biol. Chem. 6, 209-217
139. Moore, J.P., Vinh, A., Tuck, K.L., Sakkal, S., Krishnan, S.M., Chan, C.T., Lieu, M., Samuel, C.S., Diep, H., Kemp-Harper, B.K. et al. (2015) M2 macrophage accumulation in the aortic wall during angiotensin II infusion in mice is associated with fibrosis, elastin loss, and elevated blood pressure. Am. J. Physiol. Heart Circ. Physiol. 309, H906-H917
140. Ambrose, J.A. and Barua, R.S. (2004) The pathophysiology of cigarette smoking and cardiovascular disease: an update. J. Am. Coll. Cardiol. 43, 1731-1737
141. Hunter, K.A., Garlick, P.J., Broom, I., Anderson, S.E. and McNurlan, M.A. (2001) Effects of smoking and abstention from smoking on fibrinogen synthesis in humans. Clin. Sci. (Lond.) 100, 459-465
142. Hung, J., Lam, J.Y., Lacoste, L. and Letchacovski, G. (1995) Cigarette smoking acutely increases platelet thrombus formation in patients with coronary artery disease taking aspirin. Circulation 92, 2432-2436
143. Dayal, S., Wilson, K.M., Motto, D.G., Miller, Jr, F.J., Chauhan, A.K. and Lentz, S.R. (2013) Hydrogen peroxide promotes aging-related platelet hyperactivation and thrombosis. Circulation 127, 1308-1316
144. Verdoia, M., Pergolini, P., Rolla, R., Nardin, M., Schaffer, A., Barbieri, L., Marino, P., Bellomo, G., Suryapranata, H. and De Luca, G. (2016) Advanced age and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor. J. Thromb. Haemost. 14, 57-64
145. Lahousse, L., Tiemeier, H., Ikram, M.A. and Brusselle, G.G. (2015) Chronic obstructive pulmonary disease and cerebrovascular disease: a comprehensive review. Respir. Med. 109, 1371-1380
146. Mannino, D.M., Thorn, D., Swensen, A. and Holguin, F. (2008) Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur. Respir. J. 32, 962-969
147. Barr, R.G., Celli, B.R., Mannino, D.M., Petty, T., Rennard, S.I., Sciurba, F.C., Stoller, J.K., Thomashow, B.M. and Turino, G.M. (2009) Comorbidities, patient knowledge, and disease management in a national sample of patients with COPD. Am. J. Med. 122, 348-355
148. De Silva, T.M., Broughton, B.R., Drummond, G.R., Sobey, C.G. and Miller, A.A. (2009) Gender influences cerebral vascular responses to angiotensin II through Nox2-derived reactive oxygen species. Stroke 40, 1091-1097
149. Girouard, H., Lessard, A., Capone, C., Milner, T.A. and Iadecola, C. (2008) The neurovascular dysfunction induced by angiotensin II in the mouse neocortex is sexually dimorphic. Am. J. Physiol. Heart Circ. Physiol. 294, H156-H163
150. Girouard, H., Park, L., Anrather, J., Zhou, P. and Iadecola, C. (2006) Angiotensin II attenuates endothelium-dependent responses in the cerebral microcirculation through nox-2-derived radicals. Arterioscler. Thromb. Vasc. Biol. 26, 826-832
151. Girouard, H., Park, L., Anrather, J., Zhou, P. and Iadecola, C. (2007) Cerebrovascular nitrosative stress mediates neurovascular and endothelial dysfunction induced by angiotensin II. Arterioscler. Thromb. Vasc. Biol. 27, 303-309
152. Chrissobolis, S., Banfi, B., Sobey, C.G. and Faraci, F.M. (2012) Role of Nox isoforms in angiotensin II-induced oxidative stress and endothelial dysfunction in brain. J. Appl. Physiol. (1985). 113, 184-191
153. Mayhan, W.G., Arrick, D.M., Sharpe, G.M., Patel, K.P. and Sun, H. (2006) Inhibition of NAD(P)H oxidase alleviates impaired NOS-dependent responses of pial arterioles in type 1 diabetes mellitus. Microcirculation 13, 567-575
154. Miller, A.A., De Silva, T.M., Judkins, C.P., Diep, H., Drummond, G.R. and Sobey, C.G. (2010) Augmented superoxide production by Nox2-containing NADPH oxidase causes cerebral artery dysfunction during hypercholesterolemia. Stroke 41, 784-789
155. Kitayama, J., Faraci, F.M., Lentz, S.R. and Heistad, D.D. (2007) Cerebral vascular dysfunction during hypercholesterolemia. Stroke 38, 2136-2141
156. Dinh, Q.N., Drummond, G.R., Sobey, C.G. and Chrissobolis, S. (2014) Roles of inflammation, oxidative stress, and vascular dysfunction in hypertension. Biomed. Res. Int. 2014, 406960
157. Fonseca, V., Desouza, C., Asnani, S. and Jialal, I. (2004) Nontraditional risk factors for cardiovascular disease in diabetes. Endocr. Rev. 25, 153-175
158. Lindsberg, P.J. and Grau, A.J. (2003) Inflammation and infections as risk factors for ischemic stroke. Stroke 34, 2518-2532
159. Grau, A.J., Boddy, A.W., Dukovic, D.A., Buggle, F., Lichy, C., Brandt, T., Hacke, W. and Investigators, C. (2004) Leukocyte count as an independent predictor of recurrent ischemic events. Stroke 35, 1147-1152
160. Maclay, J.D., McAllister, D.A., Mills, N.L., Paterson, F.P., Ludlam, C.A., Drost, E.M., Newby, D.E. and Macnee, W. (2009) Vascular dysfunction in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 180, 513-520
161. Ives, S.J., Harris, R.A., Witman, M.A., Fjeldstad, A.S., Garten, R.S., McDaniel, J., Wray, D.W. and Richardson, R.S. (2014) Vascular dysfunction and chronic obstructive pulmonary disease: the role of redox balance. Hypertension 63, 459-467
162. Poels, M.M., Zaccai, K., Verwoert, G.C., Vernooij, M.W., Hofman, A., van der Lugt, A., Witteman, J.C., Breteler, M.M., Mattace-Raso, F.U. and Ikram, M.A. (2012) Arterial stiffness and cerebral small vessel disease: the Rotterdam Scan Study. Stroke 43, 2637-2642
163. Eickhoff, P., Valipour, A., Kiss, D., Schreder, M., Cekici, L., Geyer, K., Kohansal, R. and Burghuber, O.C. (2008) Determinants of systemic vascular function in patients with stable chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 178, 1211-1218
164. Geltser, B.I., Brodskaya, T.A., Kotelnikov, V.N., Agafonova, I.G. and Lukyanov, P.A. (2007) Endothelial dysfunction of cerebral and major arteries during chronic obstructive disease. Bull. Exp. Biol. Med. 144, 768-771
165. Van de Ven, M.J., Colier, W.N., Van der Sluijs, M.C., Kersten, B.T., Oeseburg, B. and Folgering, H. (2001) Ventilatory and cerebrovascular responses in normocapnic and hypercapnic COPD patients. Eur. Respir. J. 18, 61-68
166. van de Ven, M.J., Colier, W.N., van der Sluijs, M.C., Oeseburg, B., Vis, P. and Folgering, H. (2002) Effects of acetazolamide and furosemide on ventilation and cerebral blood volume in normocapnic and hypercapnic patients with COPD. Chest 121, 383-392
167. Albayrak, R., Fidan, F., Unlu, M., Sezer, M., Degirmenci, B., Acar, M., Haktanir, A. and Yaman, M. (2006) Extracranial carotid Doppler ultrasound evaluation of cerebral blood flow volume in COPD patients. Respir. Med. 100, 1826-1833
168. Yildiz, S., Kaya, I., Cece, H., Gencer, M., Ziylan, Z., Yalcin, F. and Turksoy, O. (2012) Impact of COPD exacerbation on cerebral blood flow. Clin. Imaging. 36, 185-190
169. Bernardi, L., Casucci, G., Haider, T., Brandstatter, E., Pocecco, E., Ehrenbourg, I. and Burtscher, M. (2008) Autonomic and cerebrovascular abnormalities in mild COPD are worsened by chronic smoking. Eur. Respir. J. 32, 1458-1465
170. Maclay, J.D., McAllister, D.A., Johnston, S., Raftis, J., McGuinnes, C., Deans, A., Newby, D.E., Mills, N.L. and MacNee, W. (2011) Increased platelet activation in patients with stable and acute exacerbation of COPD. Thorax 66, 769-774
171. Tohgi, H., Konno, S., Takahashi, S., Koizumi, D., Kondo, R. and Takahashi, H. (2000) Activated coagulation/fibrinolysis system and platelet function in acute thrombotic stroke patients with increased C-reactive protein levels. Thromb. Res. 100, 373-379
172. Emsley, H.C. and Hopkins, S.J. (2008) Acute ischaemic stroke and infection: recent and emerging concepts. Lancet Neurol. 7, 341-353
173. Palm, F., Urbanek, C. and Grau, A. (2009) Infection, its treatment and the risk for stroke. Curr. Vasc. Pharmacol. 7, 146-152
174. Denes, A., Thornton, P., Rothwell, N.J. and Allan, S.M. (2010) Inflammation and brain injury: acute cerebral ischaemia, peripheral and central inflammation. Brain Behav. Immun. 24, 708-723
175. McColl, B.W., Rothwell, N.J. and Allan, S.M. (2008) Systemic inflammation alters the kinetics of cerebrovascular tight junction disruption after experimental stroke in mice. J. Neurosci. 28, 9451-9462
176. Denes, A., Ferenczi, S. and Kovacs, K.J. (2011) Systemic inflammatory challenges compromise survival after experimental stroke via augmenting brain inflammation, blood-brain barrier damage and brain oedema independently of infarct size. J. Neuroinflammation 8, 164
177. Wu, K.L., Chan, S.H. and Chan, J.Y. (2012) Neuroinflammation and oxidative stress in rostral ventrolateral medulla contribute to neurogenic hypertension induced by systemic inflammation. J. Neuroinflammation 9, 212